dsip-bulk DSIP 5MG NAD+ 1000 mg (10 vials)

Tirzepatide for PCOS delivers significant weight loss & hormone improvements

Composition BPC-157 Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Peptide identity and purity verification via HPLC/LC-MS Studies on cellular signaling and tissue-response pathways Exploration of angiogenic and regenerative mechanisms in laboratory models Stability and solubility profiling of BPC-157 under laboratory storage conditions For qualified research professionals and institutional laboratories

TIRZEPATIDE Tirzepatide is GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist, representing a new class of medicines studied for the treatment of obesity

Stomach side effects can be more common with higher doses

Perkins MW, Pierre Z, Rezk P, Song J, Oguntayo S, Morthole V, Sciuto AM, Doctor BP, Nambiar MP

Specifically, AOD-9604 is often marketed as a targeted fat loss peptide, with claims that it can hyperfocus on reducing visceral and abdominal fat